Background: Preclinical evidence indicates that autologous bone marrow-mesenchymal stem cell (BM-MSC) transplantation improves motor function in patients with central nervous system ***: Fifty-two patients with cerebr...
详细信息
Background: Preclinical evidence indicates that autologous bone marrow-mesenchymal stem cell (BM-MSC) transplantation improves motor function in patients with central nervous system ***: Fifty-two patients with cerebral palsy (CP) who met the criteria were recruited and received BM-MSC transplantation after providing informed *** motor function was assessed using the Gross Motor Function Measure-88 (GMFM88) and GMFM66 scales at baseline (before transplantation) and the end of the 1st, 6th and 18th month post-transplantation.
暂无评论